References
- Eastman A, Schulte N, Sheibani N, Sorensen C M. Mechanisms of resistance to platinum drugs. Platinum and other metal coordination compounds in cancer chemotherapy, M Nicolini. Martinus Nijhoff, Boston 1988; 178–96
- Arrick B A, Nathan C F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 1984; 44: 4224–32
- Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472–7
- Bier H, Bergler W, Mende S, Ganzer U. Glutathione content and y-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts. Arch Otorhinolaryngol 1988; 245: 166–9
- Zenner H P, Herrmann I F, Bremer W, Stahl-Mauge C. Head and neck carcinoma models. In vivo reproduction in athymic mice and in vitro culture. Acta Otolaryngol (Stockh) 1983; 95: 371–81
- Barnes D, Sato G. Methods for growth of cultured cells in serum-free medium. Anal Biochem 1980; 102: 255–70
- Alley M C, Scudiero D A, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589–601
- Hong W S, Saijo N, Sasaki Y, et al. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines. Int J Cancer 1988; 41: 462–7
- Lowry O H, Rosebrough N J, Fair A L, Randall R J. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951; 193: 265–75
- Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502–22
- Habig W H, Jakoby W B. Glutathione-S-transferase (rat and human). Methods Enzymol 1981; 77: 218–30
- Günzler W A, Kremers H, Flohe L. An improved coupled test procedure for glutathione peroxidase (EC 1.11.19.) in blood. Z Klin Chem Klin Biochem 1974; 12: 444–8
- Bergmeyer H V, Gawehn K, Graßl M. Enzyme als biochemische Reagentien. Methoden der enzymatischen Analyse, H V Bergmayer. Verlag Chemie, Weinheim 1974; 1: 494–5
- Heydorn J. Neutron activation analysis for clinical trace element research. CRC Press, Boca Raton 1984
- Hospers G AP, Mulder N H, de Jong B, et al. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamine-dichlorplatinum (II) in vitro. Cancer Res 1988; 48: 6803–7
- Teicher B A, Holden S A, Kelley M J, et al. Characterization of a human squamous carcinoma cell line resistant to cis-diamine-dichlorplatinum (II). Cancer Res 1987; 47: 388–93
- Wang Y, Teicher B A, Holden S A, Henner W D. Cross-resistance and sulfhydryl characteristics of four human melanoma alkylating agent resistant cell lines. Proc ACCR 1989; 30: 520
- Suzukake K, Vistica B P, Vistica D T. Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content. Biochem Pharmacol 1983; 32: 165–7
- Richon V M, Schulte N, Eastman A. Multiple mechanisms of resistance to cis-diaminedichlorpla-tinum (II) in murine leukemia L1210 cells. Cancer Res 1987; 47: 2056–61
- Hamilton T C, Winker M A, Louie K G, et al. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 1985; 24: 2583–6
- Fram R J, Wilson J M, Robichaud N. Characterization of a human colon carcinoma line with acquired resistance to cis-diaminedichlorplatinum (II). Proc AACR 1989; 30: 507
- Kraker A J, Moore C W. Accumulation of cis-diaminedichloroplatinum (II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res 1988; 48: 9–13
- Ahmad S, Okine L, Wood R, Aljian J, Vistica D T. y-Glutamyl transpeptidase (y-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents. J Cell Physiol 1987; 131: 240–6
- Tew K D, Clapper M L. Glutathione S-transferase and anticancer drug resistance. Mechanisms of drug resistace in neoplastic cells, I M Goldie. Academic Press, Boston 1988; 141–59
- Andrews P A, Sriharsha V, Mann S C, Howell S B. Cis-diaminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 1988; 48: 68–73